Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury

Circulation

Volumn 94, Issue 5, 1996, Pages 1074-1082

  Lazarous, Daisy F ^a   Shou, Matie ^a   Scheinowitz, Mickey ^a   Hodge, Everett ^a   Thirumurti, Venugopal ^a   Kitsiou, Anastasia N ^a   Stiber, Jonathan A ^a   Lobo, Arlene D ^a   Hunsberger, Sally ^a   Guetta, Esther ^a   Epstein, Stephen E ^a   Unger, Ellis F ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

angiogenesis; collateral circulation; growth substances; muscle, smooth

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; COLLATERAL CIRCULATION; CORONARY ARTERY BLOOD FLOW; DOG; FEMALE; GROWTH REGULATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

EID: 9544247847     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.5.1074     Document Type: Article

References (40)

1. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev. 1992;13:18-32.
2. Klagsbrun M. The fibroblast growth factor family: structural and biological properties. Prog Growth Factor Res. 1989;1:207-235.
3. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest. 1989;84:1470-1478.
4. Gospodarowicz D, Abraham JA, Schilling J. Isolation and characterization of a vascular endothelial cell mitoyen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci U S A. 1989;86:7311-7315.
5. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 1989;161:851-858.
6. Unemori EN, Ferrara N, Bauer EA, Amento EP. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol. 1992;153:557-562.
7. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246:1306-1309.
8. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983;219:983-985.
9. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science. 1989;246:1309-1312.
10. Unger EF, Banal S, Shou M, Lazarous DF, Jaklitsch MT, Scheinowitz M, Correa R, Klingbeil C, Epstein SE. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol. 1994;266:H1588-H1595.
11. Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, Unger EF. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 1994;89:2183-2189.
12. Lazarous DF, Scheinowitz M, Shou M, Hodge E, Rajanayagam MAS, Hunsberger S, Robison WG, Stiber JA, Correa R, Epstein SE, Unger EF. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation. 1995;91:145-153.
13. Ip JH, Fuster V, Badimon L, Badimon J, Taubman MB, Chesebro JH. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle proliferation. J Am Coll Cardiol. 1990;15:1667-1687.
14. Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res. 1991;68:106-113.
15. Edelman ER, Nugent MA, Smith LT, Karnovsky MJ. Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries. J Clin Invest. 1992;89:465-473.
16. Banai S, Jaklitsch MT, Casscells W, Shou M, Shrivastav S, Correa R, Epstein SE, Unger EF. Effects of acidic fibroblast growth factor on normal and ischemic myocardium. Circ Res. 1991;69:76-85.
17. Nabel EG, Yang ZY, Plautz G, Forough R, Zhan X, Haudenschild CC, Maciag T, Nabel GJ. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature. 1993;362:844-846.
18. Asahara T, Bauters C, Pastore C, Kearney M, Rossow S, Bunting S, Ferrara N, Symes JF, Isner JM. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation. 1995;91:2793-2801.
19. Litvak J, Siderides LE, Vineberg AM. Experimental production of coronary artery insufficiency and occlusion. Am Heart J. 1957;53:505-518.
20. Heymann MA, Payne BD, Hoffman JIE, Rudolph AM. Blood flow measurements with radionuclide-labelled particles. Prog Cardiovasc Dis. 1971;20:55-79.
21. Bretschneider HJ, Eberlein HJ, Kabus HM, Nelle G, Reichmann W. Die Wirkungen von 3-(β-Diäthylamino-äthyl)-4-methyl-7-carbäthoxy-methoxy-2- oxo-(1,2-chromen), einer selektiv coronarerweiternden Substanz, auf Kreislauf, Atmung und Stoffwechsel. Arzneimittelforschung. 1963;13:255-268.
22. Baer RW, Payne BD, Verrier ED, Vlahakes GJ, Molodowitch D, Uhlig PN, Hoffman JIE. Increased number of myocardial blood flow measurements with radionuclide-labeled microspheres. Am J Physiol. 1984;246:H418-H434.
23. Movat H. Demonstration of all connective tissue elements in a single section. Arch Pathol Lab Med. 1955;60:289-295.
24. Gabbiani G, Kocher O, Bloom WS. Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media. J Clin Invest. 1984;74:148-152.
25. Banai S, Shou M, Correa R, Jaklitsch MT, Epstein SE, Unger EF. The rabbit ear model of injury-induced arterial smooth muscle cell proliferation: kinetics, reproducibility, and implications. Circ Res. 1991;69:748-756.
26. Cuevas P, Carceller F, Ortega S, Zazo M, Nieto I, Giménez-Gallego G. Hypotensive activity of fibroblast growth factor. Science. 1991;254:1208-1210.
27. Dowdy S, Wearden S. Statistics for Research. New York, NY: John Wiley & Sons. Inc; 1983.
28. Flugelman MY, Virmani R, Correa R, Yu Z-Y, Farb A, Leon MB, Elami A, Fu Y-M, Casscells W, Epstein SE. Smooth muscle cell abundance and fibroblast growth factors in coronary lesions of patients with nonfatal unstable angina: a clue to the mechanism of transformation from the stable to the unstable clinical state. Circulation. 1993;88:2493-2500.
29. Cohen MV. Coronary Collaterals: Clinical and Experimental Observations. Mount Kisco, NY: Futura; 1985:419-446.
30. Ku DD, Zaleski JK, Liu S, Brock TA. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol. 1993;265:H586-H592.
31. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM. Therapeutic angiogenesis: a single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest. 1994;93:662-670.
32. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM. Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vasc Surg. 1995;21:314-325.
33. Austin GE, Ratliff NB, Hollman J, Tabei S, Phillips DF. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1985;6:369-375.
34. Giraldo AA, Esposo OM, Meis JM. Intimai hyperplasia as a cause of restenosis after percutaneous transluminal coronary angioplasty. Arch Pathol Lab Med. 1985;109:173-175.
35. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan Y-CE, Olander JV, Connolly DT, Stern D. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med. 1990;172:1535-1545.
36. Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Suenram CA, Rozek MM. Atherosclerosis as an inflammatory process: the roles of the monocyte-macrophage. Ann N Y Acad Sci. 1985;454:115-120.
37. Isner JM, Walsh K, Symes J, Pieczek A, Takeshita S, Lowry J, Rossow S, Rosenfield K, Weir L, Brogi E, Schainfeld R. Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. Circulation. 1995;91:2687-2692.
38. Mazué G, Bertolero F, Jacob C, Sarmientos P, Roncucci R. Preclinical and clinical studies with recombinant human basic fibroblast growth factor. Ann N Y Acad Sci. 1991;638:329-340.
39. Mazué G, Bertolero F, Garofano L, Brughera M, Carminati P. Experience with the preclinical assessment of basic fibroblast growth factor (bFGF). Toxicol Lett. 1992;64-65:329-338.
40. Mazué G, Newman AJ, Scampini G, Torre PD, Hard GC, Iatropoulos MJ, Williams GM, Bagnasco SM. The histopathology of kidney changes in rats and monkeys following intravenous administration of massive doses of FCE 26184, human basic fibroblast growth factor. Toxicol Pathol. 1993;21:490-501.